Global Investor Forum Contact

Thibault Helleputte

CEO & Founder, DNAlytics


11:30 - 12:45 hours
From general to personalized

Thibault Helleputte (Belgium 1982) got an Engineering degree in Computing Sciences from the University of Louvain (UCL 2006), a PhD in Engineering Sciences (UCL 2010) under supervision of Prof. Dupont (Engineering Faculty) and Sokal (Medicine Faculty), and an MBA from the Louvain School of Management (LSM, 2012). From 2010 to 2013, he worked on a Spin-Off Project, developing new data-driven precision medicine solutions. His work received several awards, from IBM, the Microsoft Innovation Center or the MIT. He founded DNAlytics in 2012, which he runs since. DNAlytics develops data-driven precision medicine solutions namely in Rheumatology (RheumaKit) and Oncology (ColonoKit).


Data science for biological drugs prescription
The mechanism of action of biologics is often well known, most of the time even by design. Yet, using this information and characterizing the metabolic status of each patient before prescribing such drugs is not the standard care yet. Arthritis management is no exception, although it is the main source of public health expense in most developed countries. In this talk, we will introduce RheumaKit, a precision medicine platform combining transcriptomic and data science to promote more informed therapeutic decisions.
Niels Chavannes
Maarten van Dongen
Ingmar de Gooijer
Mark van Houdenhoven
Sint Maartenskliniek

Henk van Houten

Arthur Lahr
Kiadis Pharma

Jos Malda
UMC Utrecht
Eveliene Manten-Horst
AYA Jongvolwassen & Kanker

Madelon Maurice
UMC Utrecht

Tom Miller
GreyBird Ventures
Edwin Moses
Kees Recourt
Mibiton Foundation

Maurits van Selms

Marianne van der Steen
Markwin Velders
Kite Pharma
Werner Verbiest
Janssen Diagnostics
Eline Vrijland-van Beest
Sponsors & Partners
Main partner
Host sponsor
Host sponsor
Host sponsor
Platinum sponsor
Gold sponsor
Award sponsor
Your logo?
© 2018 Innovation for Health